• Mtb Survival via BMX Kinase–Mediated Inhibition of Lysosomal

  2026-06-10

  The reference study uncovers how Mycobacterium tuberculosis (Mtb) exploits host BMX kinase to phosphorylate the V-ATPase subunit ATP6V1E1, suppressing lysosomal acidification and promoting intracellular persistence. These mechanistic insights highlight BMX kinase–mediated phosphorylation as a promising target for host-directed tuberculosis therapies.

• Prevotella copri–Mediated IPyA Depletion Accelerates Breast

  2026-06-10

  This study uncovers how enrichment of Prevotella copri in the gut microbiota promotes breast cancer progression through depletion of the host’s intrinsic indole-3-pyruvic acid (IPyA), inactivating AMPK signaling via UHRF1 regulation. These findings establish a mechanistic link between microbial metabolism and epigenetic cancer drivers, highlighting new directions for metabolic and microbiome-targeted research.

• Applied Use of BIIE 0246: Neuropeptide Y Y2 Receptor Antagon

  2026-06-09

  BIIE 0246 stands out as a potent, selective neuropeptide Y Y2 receptor antagonist, enabling advanced dissection of NPY-mediated pathways in neuroscience and cardiometabolic research. This article translates key experimental principles and recent innovations—such as adipose-neural axis modeling—into practical, stepwise workflows and troubleshooting strategies for rigorous, reproducible results.

• Refining In Vitro Assessment of Anti-Cancer Drug Responses

  2026-06-09

  Schwartz (2022) introduces a rigorous framework for in vitro evaluation of anti-cancer drugs, dissecting the interplay between proliferative arrest and cell death. This approach clarifies mechanistic drug action, supporting more precise preclinical screening and interpretation.

• Structural Insights into ASCH Domains and N4-Acetylcytidine

  2026-06-08

  Meng et al. present the first high-resolution structural and mechanistic analysis of ASCH domain-containing proteins, defining the catalytic mechanism and substrate specificity of EcYqfB in converting N4-acetylcytidine to cytidine. These findings clarify the biochemical role of EcYqfB and its homologs in nucleotide metabolism, with direct implications for RNA epigenetics and post-transcriptional modification studies.

• Tamoxifen: Applied Workflows for Gene Knockout & Cancer Rese

  2026-06-08

  Tamoxifen is an essential selective estrogen receptor modulator for advanced breast cancer models and inducible gene knockout workflows. This article delivers actionable protocols, troubleshooting strategies, and comparative insights that maximize the reliability and scientific impact of Tamoxifen in translational research.

• Rosiglitazone (SKU A4304): Reliable Advances in Metabolic As

  2026-06-07

  This article addresses routine and emerging laboratory challenges in metabolic research, focusing on how Rosiglitazone (SKU A4304) from APExBIO enables reproducible, data-driven solutions. Drawing on recent functional studies and practical Q&A scenarios, it guides researchers in optimizing protocols, interpreting results, and making sound product choices for cell viability, adipogenesis, and insulin sensitivity assays.

• Linoleic Acid (C18:2(9Z,12Z)): Signaling, Ketogenesis, and A

  2026-06-06

  Explore the multifaceted role of Linoleic Acid in cellular signaling, ketogenesis, and innovative assay development. This in-depth article integrates new mechanistic insights and practical workflow guidance—distinct from previous content on C18:2(9Z,12Z).

• Dual-Network Hydrogel Microspheres for IVDD: Inflammation Mo

  2026-06-05

  This study introduces a multifunctional, elastic dual-network hydrogel microsphere platform for targeted delivery of miRNA therapeutics in intervertebral disc degeneration (IVDD). By enabling responsive, localized suppression of inflammation and inhibition of apoptosis, the system restores nucleus pulposus cell function and represents a promising approach for IVDD management.

• (S)-(+)-Dimethindene maleate: Selective M2 Muscarinic Antago

  2026-06-05

  (S)-(+)-Dimethindene maleate provides researchers with a highly selective tool for antagonizing the M2 muscarinic acetylcholine receptor, with minimal interaction at other muscarinic subtypes and concurrent H1 antagonism. It is best suited for studies on autonomic regulation, cardiovascular, and respiratory physiology, but is not appropriate for diagnostic or clinical applications. Researchers should follow precise dosing and handling protocols to ensure integrity and reproducibility in experimental workflows.

• CENPI Drives Breast Cancer Progression via Wnt/β-Catenin Mod

  2026-06-04

  Wu et al. reveal that centromere protein I (CENPI) promotes breast cancer tumorigenesis and disease advancement by activating the Wnt/β-catenin signaling pathway. Their integrative approach—combining transcriptomic analysis, functional experiments, and bioluminescence reporter assays—identifies CENPI as a promising biomarker and potential therapeutic target for breast cancer.

• Cucurbitacin I (JSI-124): Precision STAT3 Inhibition in Canc

  2026-06-04

  Explore how Cucurbitacin I enables selective STAT3 pathway inhibition in cancer research. This article offers a deep dive into its mechanism, practical protocols, and novel insights for experimental design, setting it apart from standard protocol overviews.

• Synthetic Viability with ERCC1 Deficiency in Lung Cancer: Me

  2026-06-03

  This paper uncovers how ERCC1-deficient lung cancer cells can acquire synthetic viability in response to interstrand crosslinking agents, with p53 status critically modulating this effect. The findings reshape our understanding of platinum chemotherapy response and highlight the need to consider DNA repair context and tumor suppressor status in translational oncology research.

• Efficient Synthesis of Deuterium-Labeled Degarelix Acetate

  2026-06-03

  This study presents a robust, multi-step method for synthesizing deuterium-labeled degarelix acetate, a GnRH receptor antagonist critical for pharmacokinetic and metabolism studies of androgen-related diseases. The approach leverages D2O/D3PO4 as a deuterium source and careful peptide synthesis, enabling production of stable isotope-labeled standards for clinical and ADME research.

• AIBP-LRP2-HDL Axis Restricts CXCR4+ Capillary Expansion in I

  2026-06-02

  This study uncovers how the AIBP-LRP2-mediated uptake of HDL-associated miR-223 restricts the expansion of CXCR4+ stemlike capillary endothelial cells (CECs), thereby controlling collateral vessel formation in ischemic tissues. These findings clarify previously unknown mechanisms of vascular remodeling, providing new molecular targets for therapeutic revascularization.

450 records 15/30 page Previous Next First page 上5页 1112131415 下5页 Last page